Illumina
Venture capital · San Diego, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
4Deep-tech portfolio2 active
2Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Grail
8Co-investorsShare a portfolio company
Portfolio · 4 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Oxford Nanopore Technologies | Biotech | Active | — | — |
| Pacific Biosciences | Semiconductors | Active | — | — |
| Grail | Medtech | Public | Nov 7, 2025 | $1.7B |
| Singular Genomics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#108
Portfolio exits#103
Raises, 12 months#22
Co-investors#173
Co-investors
- Andreessen HorowitzVenture capital1 shared
- Breakthrough Energy VenturesVenture capital1 shared
- Bristol-Myers SquibbVenture capital1 shared
- Gilead SciencesVenture capital1 shared
- Gordon and Betty Moore FoundationVenture capital1 shared
- Johnson & Johnson Development CorporationVenture capital1 shared
- Thermo Fisher ScientificVenture capital1 shared
- Venrock Healthcare Capital PartnersVenture capital1 shared
Sectors
- Biotech2
- Medtech1
- Semiconductors1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.